Adipotide 2mg
Adipotide (FTPP/Prohibitin-TP01) is a chimeric peptide that targets and destroys blood vessels feeding white adipose tissue. The targeting domain (CKGGRAKDC) binds to prohibitin on adipose vasculature endothelium, while the effector domain D(KLAKLAK)2 induces mitochondrial membrane disruption and apoptosis. Primate studies showed significant fat reduction.
Sequence
CKGGRAKDC-GG-D(KLAKLAK)2 chimeric peptide
Market avg: $64.99 — save 42%
Volume pricing
Pay with USDC via Coinbase Commerce
Certificate of Analysis
Independently verified by Janoshik Analytical
Test ID
JAN-ADIPO-2026-001
Purity
96.5%
Method
HPLC-MS
Batch
ADIPO-2026-01A
Test Date
February 1, 2026
Identity
Confirmed
Storage Requirements
Lyophilized
-20°C, protect from light
Reconstituted
2-8°C, use within 7 days
Pro-apoptotic targeting peptide. Handle with care. Store frozen.
Published Research
1 peer-reviewed studies
Targeted apoptosis of the adipose vasculature produces rapid weight loss in obese primates
Barnhart KF, Christianson DR, Hanley PW, et al. — Science Translational Medicine, 2011
Primate study demonstrating adipotide-induced fat loss through targeted vascular apoptosis.
Related Products
Research use only. All products are sold strictly for in-vitro research purposes only. Not for human consumption. Information provided references published research literature. No medical claims are made or implied.